Use of glucocorticoids in the critical care setting: Science and clinical evidence.

Abstract:

:Glucocorticoids (GC) in all its various forms and formulations are likely one of the most commonly used pharmacologic agents in medicine. Their use can be profoundly therapeutic but are also associated with a myriad of acute and chronic side effects. It is fairly well-accepted in the medical community that GC can be life-saving when used in critically ill patients with severe exacerbations of asthma and chronic obstructive pulmonary disease, HIV-associated pneumocystosis, and systemic vasculitides. However, the adjunctive role of GC is much more controversial in acute respiratory distress syndrome (ARDS), septic shock, community-acquired pneumonia, and several other serious medical conditions. Despite such controversies, GC should at least be considered for patients with fulminant manifestations of the following conditions as there is equipoise to indicate that GC may improve outcome with acceptable risks: (i) severe ARDS with refractory hypoxemia despite one to two weeks of state-of-the-art management, (ii) recalcitrant, vasopressor-dependent septic shock, (iii) non-influenza, severe community-acquired pneumonia, and (iv) severe alcoholic hepatitis. The bases for these controversies is likely due to both host factors (e.g., differences in GC resistance and susceptibility to adverse effects) and different phenotypes of any one disease state; e.g., different pathogenesis and pathogens under the rubric of "sepsis." Elucidation of better biomarkers to determine the underlying pathogenic phenotype will significantly advance our understanding and prediction of which critically ill patients will benefit from GC and who would experience a deleterious effect from its use.

journal_name

Pharmacol Ther

authors

Chan ED,Chan MM,Chan MM,Marik PE

doi

10.1016/j.pharmthera.2019.107428

subject

Has Abstract

pub_date

2020-02-01 00:00:00

pages

107428

eissn

0163-7258

issn

1879-016X

pii

S0163-7258(19)30180-9

journal_volume

206

pub_type

杂志文章,评审
  • Clues to asthma pathogenesis from microarray expression studies.

    abstract::Asthma is a chronic inflammatory disease characterized by airway hyperresponsiveness (AHR), tissue remodeling, and airflow obstruction. The pathogenesis of asthma is only partly understood, and there is an urgent need for improved therapeutic strategies for this disease. Microarray technology has considerable promise ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.08.009

    authors: Rolph MS,Sisavanh M,Liu SM,Mackay CR

    更新日期:2006-01-01 00:00:00

  • Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease.

    abstract::The organized, tightly regulated signaling relays engaged by the cannabinoid receptors (CBs) and their ligands, G proteins and other effectors, together constitute the endocannabinoid system (ECS). This system governs many biological functions including cell proliferation, regulation of ion transport and neuronal mess...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2017.06.003

    authors: Badal S,Smith KN,Rajnarayanan R

    更新日期:2017-12-01 00:00:00

  • Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis.

    abstract::Osteoporosis is defined as a progressive systemic skeletal disease characterised by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. The clinical relevance of osteoporosis derives from the fractures that it produces. More th...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(02)00164-x

    authors: Rodríguez-Martínez MA,García-Cohen EC

    更新日期:2002-01-01 00:00:00

  • The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

    abstract::Methamphetamine (METH) abuse is a major public health issue around the world, yet there are currently no effective pharmacotherapies for the treatment of METH addiction. METH is a potent psychostimulant that increases extracellular dopamine levels by targeting the dopamine transporter (DAT) and alters neuronal activit...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2018.01.009

    authors: Sambo DO,Lebowitz JJ,Khoshbouei H

    更新日期:2018-06-01 00:00:00

  • Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.

    abstract::Forward Pharmacology seeks to identify small or large molecules that modulate a normal or abnormal biological process in living cells or whole organisms and historically has been responsible for the discovery of many clinically used drugs. Forward Pharmacology approaches have become particularly attractive because adv...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.03.002

    authors: Vogt A,Lazo JS

    更新日期:2005-08-01 00:00:00

  • Contribution of metabotropic GABA(B) receptors to neuronal network construction.

    abstract::In the 1980s, Bowery and colleagues discovered the presence of a novel, bicuculline-resistant and baclofen-sensitive type of GABA receptor on peripheral nerve terminals, the GABA(B) receptor. Since this pioneering work, GABA(B) receptors have been identified in the Central Nervous System (CNS), where they provide an i...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2011.06.004

    authors: Gaiarsa JL,Kuczewski N,Porcher C

    更新日期:2011-11-01 00:00:00

  • Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future.

    abstract::The past three decades have witnessed a welcome expansion of the therapeutic armamentarium for the management of pulmonary arterial hypertension (PAH). However, against this backdrop, there have been some notable disappointments in drug development. Here we use these as case studies to emphasize the importance of info...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2016.04.012

    authors: Lythgoe MP,Rhodes CJ,Ghataorhe P,Attard M,Wharton J,Wilkins MR

    更新日期:2016-08-01 00:00:00

  • Measurement of sister chromatid exchanges and their relationship to DNA damage, repair and cell killing.

    abstract::We have concentrated on how SCE is measured, how it correlates with other measures of cellular damage, and how SCE can be used as a tool to study cell cycle kinetics. We have not discussed the biological significance of SCEs, i.e. why they occur spontaneously, and what role, if any, in cellular preservation they play....

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(89)90030-2

    authors: Deen DF,Morgan WF,Tofilon PJ,Barcellos-Hoff MH

    更新日期:1989-01-01 00:00:00

  • The role of CB1 in immune modulation by cannabinoids.

    abstract::There is clear evidence that CB(2), historically referred to as the peripheral cannabinoid receptor, mediates many of the immune modulatory effects of cannabinoids. However, cannabinoid receptors cannot be classified simply as central or peripheral since CB(2) has been shown to play a role in the central nervous syste...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2012.12.004

    authors: Kaplan BL

    更新日期:2013-03-01 00:00:00

  • Targeting the glucagon receptor family for diabetes and obesity therapy.

    abstract::Diabetes is a debilitating disease characterized by chronic hyperglycemia and is often associated with obesity. With diabetes and obesity incidence on the rise, it is imperative to develop novel therapeutics that will not only lower blood glucose levels, but also combat the associated obesity. The G protein-coupled re...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2012.05.009

    authors: Cho YM,Merchant CE,Kieffer TJ

    更新日期:2012-09-01 00:00:00

  • Therapeutic aspects of polymorphic epithelial mucin in adenocarcinoma.

    abstract::The gene MUC1 encodes a large membrane-associated glycoprotein, previously termed polymorphic epithelial mucin and now known as MUC1. The majority of the extracellular domain is made up of tandem repeats of 20 amino acids. In some epithelial malignancies, MUC1 is up-regulated, and as a result of changes in glycosyl an...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(99)00003-0

    authors: Miles DW,Taylor-Papadimitriou J

    更新日期:1999-04-01 00:00:00

  • Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

    abstract::Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a high social cost. Depressed patients generally display co-morbid symptoms, and depression frequently accompanies other serious disorders. Currently available drugs display limited efficacy and a pronounced delay to onset o...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.11.006

    authors: Millan MJ

    更新日期:2006-05-01 00:00:00

  • Acquisition of inhibitor-sensitive protein kinases through protein design.

    abstract::Protein phosphorylation is the major post-translational modification used by eukaryotic cells to control cellular signaling. Protein kinases have emerged as attractive drug targets because heightened protein kinase activity has been associated with several proliferative diseases, most notably cancer and restenosis. Un...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(98)00060-6

    authors: Bishop AC,Shokat KM

    更新日期:1999-05-01 00:00:00

  • Pericytes, mesenchymal stem cells and their contributions to tissue repair.

    abstract::Regenerative medicine using mesenchymal stem cells for the purposes of tissue repair has garnered considerable public attention due to the potential of returning tissues and organs to a normal, healthy state after injury or damage has occurred. To achieve this, progenitor cells such as pericytes and bone marrow-derive...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2015.03.006

    authors: Wong SP,Rowley JE,Redpath AN,Tilman JD,Fellous TG,Johnson JR

    更新日期:2015-07-01 00:00:00

  • Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.

    abstract::This article is a review of cyclic nucleotide phosphodiesterase(s) (CN PDE) from the point of view of the relationships between the newer aspects of the complex enzymology of CN PDE and recent major advances in CN PDE pharmacology. A consolidation of isozyme nomenclature to the proposed family designations is recommen...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(91)90039-o

    authors: Thompson WJ

    更新日期:1991-01-01 00:00:00

  • Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms.

    abstract::gamma-Aminobutyric acid(A) (GABA(A)) receptors are ligand-gated ion channels that, predominantly, mediate inhibitory synaptic transmission in the CNS. These receptors are pentameric complexes that are comprised of subunits from several classes (alpha, beta, gamma, delta, ), with each class consisting of several isofor...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2003.12.001

    authors: Kumar S,Fleming RL,Morrow AL

    更新日期:2004-03-01 00:00:00

  • Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF.

    abstract::A common feature of chronic respiratory disease is the progressive decline in lung function. The decline can be indolent, or it can be accelerated by acute exacerbations, whereby the patient experiences a pronounced worsening of disease symptoms. Moreover, acute exacerbations may also be a marker of insufficient disea...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2016.11.003

    authors: Murray LA,Grainge C,Wark PA,Knight DA

    更新日期:2017-01-01 00:00:00

  • The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.

    abstract::The cardiovascular system is highly organised in time; blood pressure (BP), heart rate (HR), peripheral resistance, pressure and the release/activity of vasodilating hormones all display pronounced circadian variations. Pathophysiological events within the cardiovascular system are also not random, as shown for instan...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.11.008

    authors: Lemmer B

    更新日期:2006-09-01 00:00:00

  • Clinical benefits and pharmacology of scutellarin: A comprehensive review.

    abstract::Stroke and myocardial infarction are among the most common causes of mortality and disability in the world. The ischemic injury underlying these illnesses is complex, involving intricate interplays among many biological functions including energy metabolism, vascular regulation, hemodynamics, oxidative stress, inflamm...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2018.05.006

    authors: Wang L,Ma Q

    更新日期:2018-10-01 00:00:00

  • Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes.

    abstract::Microsomal P450-mediated monooxygenase activity supported by NADPH requires an interaction between flavoprotein NADPH-cytochrome P450 reductase and cytochrome P450. These proteins have been identified as the simplest system (with the inclusion of a phospholipid (PL) component) that possesses monooxygenase function; ho...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(03)00031-7

    authors: Backes WL,Kelley RW

    更新日期:2003-05-01 00:00:00

  • Metabolic zonation of the liver: regulation and implications for liver function.

    abstract::Liver parenchyma shows a remarkable heterogeneity of the hepatocytes along the porto-central axis with respect to ultrastructure and enzyme activities resulting in different cellular functions within different zones of the liver lobuli. According to the concept of metabolic zonation, the spatial organization of the va...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(92)90055-5

    authors: Gebhardt R

    更新日期:1992-01-01 00:00:00

  • HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting.

    abstract::The human epidermal growth factor receptor (HER) family members are targeted by a growing numbers of small molecules and monoclonal antibodies. Resistance against the epidermal growth factor receptor (EGFR) and HER2-targeting agents is a clinically relevant problem forcing research on optimizing targeting of the HER f...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2014.01.005

    authors: Kol A,Terwisscha van Scheltinga AG,Timmer-Bosscha H,Lamberts LE,Bensch F,de Vries EG,Schröder CP

    更新日期:2014-07-01 00:00:00

  • Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.

    abstract::The widespread coronavirus SARS-CoV-2 has already infected over 4 million people worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies mainly on antiviral drugs lopinavir/ritonavir, arbidol, and remdesivir, the anti-malarial drugs hydroxychloroquine and chloroquine, and traditional C...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107587

    authors: Liu T,Luo S,Libby P,Shi GP

    更新日期:2020-09-01 00:00:00

  • Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis.

    abstract::Cardiovascular disease (CVD) continues to be a leading cause of death worldwide with atherosclerosis being the major underlying pathology. The interplay between lipids and immune cells is believed to be a driving force in the chronic inflammation of the arterial wall during atherogenesis. Atherosclerosis is initiated ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2018.08.012

    authors: Lacy M,Atzler D,Liu R,de Winther M,Weber C,Lutgens E

    更新日期:2019-01-01 00:00:00

  • The role of transporters in cellular heme and porphyrin homeostasis.

    abstract::Heme, a complex of iron and protoporphyrin IX (PPIX), senses and utilizes oxygen in nearly all living cells. It is an essential component of various hemoproteins, including those involved in oxygen transport and storage (hemoglobin, myoglobin), electron transfer, drug and steroid metabolism (cytochromes), and signal t...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2007.02.001

    authors: Krishnamurthy P,Xie T,Schuetz JD

    更新日期:2007-06-01 00:00:00

  • Delta opioid receptors in brain function and diseases.

    abstract::Evidence that the delta opioid receptor (DOR) is an attractive target for the treatment of brain disorders has strengthened in recent years. This receptor is broadly expressed in the brain, binds endogenous opioid peptides, and shows as functional profile highly distinct from those of mu and kappa opioid receptors. Ou...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2013.06.003

    authors: Chu Sin Chung P,Kieffer BL

    更新日期:2013-10-01 00:00:00

  • Pericytes for the treatment of orthopedic conditions.

    abstract::Pericytes and other perivascular stem cells are of growing interest in orthopedics and tissue engineering. Long regarded as simple regulators of angiogenesis and blood pressure, pericytes are now recognized to have MSC (mesenchymal stem cell) characteristics, including multipotentiality, self-renewal, immunoregulatory...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2016.08.003

    authors: James AW,Hindle P,Murray IR,West CC,Tawonsawatruk T,Shen J,Asatrian G,Zhang X,Nguyen V,Simpson AH,Ting K,Péault B,Soo C

    更新日期:2017-03-01 00:00:00

  • Intestinal toxicity of non-steroidal anti-inflammatory drugs.

    abstract::We review the adverse effect of non-steroidal anti-inflammatory drugs (NSAIDs) on the small and large intestine. NSAIDs cause small intestinal inflammation in 65% of patients receiving the drugs long-term. The clinical implications of NSAID-induced enteropathy are that patients bleed and lose protein from the inflamma...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(94)90008-6

    authors: Bjarnason I,Macpherson AJ

    更新日期:1994-04-01 00:00:00

  • Nicotinic acetylcholine receptors: from basic science to therapeutics.

    abstract::Substantial progress in the identification of genes encoding for a large number of proteins responsible for various aspects of neurotransmitter release, postsynaptic detection and downstream signaling, has advanced our understanding of the mechanisms by which neurons communicate and interact. Nicotinic acetylcholine r...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2012.08.012

    authors: Hurst R,Rollema H,Bertrand D

    更新日期:2013-01-01 00:00:00

  • Imaging inflammation: molecular strategies to visualize key components of the inflammatory cascade, from initiation to resolution.

    abstract::Dysregulation of inflammation is central to the pathogenesis of innumerable human diseases. Understanding and tracking the critical events in inflammation are crucial for disease monitoring and pharmacological drug discovery and development. Recent progress in molecular imaging has provided novel insights into spatial...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2012.05.006

    authors: Dorward DA,Lucas CD,Rossi AG,Haslett C,Dhaliwal K

    更新日期:2012-08-01 00:00:00